MUC2 is expressed by mucinous adenocarcinomas of the colon, breast, pancreas and ovary4. CDX-2 may interact with the MUC2 promoter, activating MUC2 expression4.
|
MUC1 (EMA) |
MUC2 |
MUC5AC |
||
breast |
normal mammary gland |
10/101 |
0/101 |
0/101 |
|
ductal carcinoma |
13/131 |
0/131 |
0/131 |
||
GI tract |
stomach |
|
|
positive1 |
|
pancreas |
positive1 |
|
|
||
intestinal goblet cell |
|
positive1 |
|
||
rectal mucosa |
0/101 |
10/101 |
3/101 |
||
anal glands |
0/61 |
0/61 |
6/61 |
||
renal cell carcinoma |
26/601 |
|
|
||
vulva |
eccrine glands |
12/121 |
0/121 |
0/121 |
|
apocrine glands |
8/81 |
0/81 |
0/81 |
||
mammary-like glands |
6/61 |
0/61 |
0/61 |
||
Bartholin's glands |
7/71 |
0/71 |
7/71 |
||
cervix |
endocervical glands |
|
|
positive1 |
|
normal endocervical glandular epithelium |
11/11, in 50% to 100% of cells |
normal ectocervical squamous epithelium |
4/18, focally in parabasal cells |
squamous metaplasia |
7/9, in 10% to 50% of parabasal cells |
CIN I |
17/19, in all layers of the epithelium |
CIN II |
7/7, in all layers of the epithelium |
CIN III |
9/9, in all layers of the epithelium |
References
This page last revised 11.9.2005.
©SMUHT/PW Bishop